of migraine. more than 4 million of them have at least 15 migraine days each month. even though many drugs prevent and treat these headaches,
.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
.
'indian ip and liabilities law barrier to pharma r&d investment'
. to see how we safeguard and use the information you provide us with. if your facebook account does not have an attached e-mail address, you'll need to add that before you can sign up.
.
.